Skip to Content

Sancuso Approval History

  • FDA approved: Yes (First approved September 12th, 2008)
  • Brand name: Sancuso
  • Generic name: granisetron
  • Dosage form: Transdermal Patch
  • Company: ProStrakan Group plc
  • Treatment for: Nausea/Vomiting, Chemotherapy Induced

Sancuso (granisetron transdermal system) is an anti-emetic transdermal delivery system indicated for the control of nausea and vomiting in patients receiving moderately and/or highly nausea-inducing chemotherapy.

Development History and FDA Approval Process for Sancuso

Sep 15, 2008Approval FDA Approves Sancuso, the First and Only Patch for Preventing Nausea and Vomiting in Cancer Patients Undergoing Chemotherapy
Jun  2, 2008ProStrakan Presents Update on Sancuso US Regulatory Review Status

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.